BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Genentech’s Tecentriq-Avastin-Chemo Combo Dazzles in Late-Stage Study

  Patients who received Tecentriq and Avastin in addition to standard chemo showed a 38 percent reduction in the risk of the disease getting worse or death.

  December 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Unwanted Light Shines on AstraZeneca and Its Blockbuster Seroquel

  Taking Seroquel with methadone can be fatal. Did the drugmaker’s warnings fall short?

  December 7, 2017

   · 

  1 min read
• 

  Drug Development

  Sage Therapeutics Erupts as Depression Drug Wows in Mid-Stage Study

  Shares of Sage have shot up more than 75 percent this morning as a result of the impressive data.

  December 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Top 3 Biotech Stocks to Buy in 2018

  Here’s a look at three promising biotech stocks.

  December 7, 2017

   · 

  3 min read
• 

  Business

  San Diego’s Halozyme Lands Potential $680M R&D Deal With Alexion

  Alexion will use Halozyme’s ENHANZE drug-delivery technology to develop subcutaneous formulations for that company’s portfolio of products.

  December 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Pfizer Denies Fumes From Viagra Factory are Arousing Irish Town’s Males

  “One whiff and you’re stiff.” Residents of Ringaskiddy, Ireland are feeling arousing effects from breathing the air near the local Pfizer plant that manufactures Viagra.

  December 7, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Stryker Slams Down $662M for Entellus Medical

  Entellus’ ENT portfolio is led by e XprESS Multi-Sinus Dilation System and the LATERA Absorbable Nasal Implant.

  December 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  What You Need to Know About Freenome

  Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called “liquid biopsy,” in other words, blood.

  December 7, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Spark, Pfizer’s Gene Therapy Hemophilia B Drug Stuns in Trial

  Spark Therapeutics, with its partner Pfizer, published interim data from its Phase I/II clinical trial of a gene therapy for hemophilia B in The New England Journal of Medicine.

  December 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• Genova Biotech (Changzhou) Raises $50M in Tasly-Led Funding

  With the latest funding, Genova has raised $200M in capital.

  December 7, 2017

   · 

  1 min read